GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abeona Therapeutics Inc (LTS:0H7R) » Definitions » Accounts Payable

Abeona Therapeutics (LTS:0H7R) Accounts Payable : $2.79 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Abeona Therapeutics Accounts Payable?

Abeona Therapeutics's Accounts Payable for the quarter that ended in Sep. 2024 was $2.79 Mil.

Abeona Therapeutics's quarterly Accounts Payable declined from Mar. 2024 ($3.36 Mil) to Jun. 2024 ($3.10 Mil) and declined from Jun. 2024 ($3.10 Mil) to Sep. 2024 ($2.79 Mil).

Abeona Therapeutics's annual Accounts Payable declined from Dec. 2021 ($4.33 Mil) to Dec. 2022 ($1.81 Mil) but then increased from Dec. 2022 ($1.81 Mil) to Dec. 2023 ($1.86 Mil).


Abeona Therapeutics Accounts Payable Historical Data

The historical data trend for Abeona Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abeona Therapeutics Accounts Payable Chart

Abeona Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.76 4.70 4.33 1.81 1.86

Abeona Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.59 1.86 3.36 3.10 2.79

Abeona Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Abeona Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Abeona Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Abeona Therapeutics Business Description

Traded in Other Exchanges
Address
6555 Carnegie Avenue, 4th Floor, Cleveland, OH, USA, 44103
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

Abeona Therapeutics Headlines

No Headlines